INTRODUCTION {#S5}
============

Waist circumference (WC), the established surrogate for central obesity,([@R1], [@R2], [@R3], [@R4]) is continuing to gain importance as a potential screening method for Type 2 diabetes (T2D) and insulin resistance (IR).([@R5], [@R6], [@R7]) Evidence for the association of WC with these conditions has been gleaned mostly from epidemiological studies.([@R8], [@R9], [@R10], [@R11]) Recently some family based studies have also offered associations compatible with these epidemiological observations.([@R12]) Waist circumference is strongly associated with visceral rather than subcutaneous fat ([@R13], [@R14], [@R15], [@R16]) as well as commonly used clinical indexes of lipemic status like total serum cholesterol, serum triglycerides and serum high-density lipoprotein (HDL) cholesterol.([@R17]) On the other hand, reasons ([@R18]) for not favoring the use of WC for identification or stratification of T2D risk include i) WC correlates strongly with body mass index (BMI);([@R19]) ii) WC cannot distinguish between subcutaneous and visceral fat; iii) age- and sex-adjusted models do not offer a convincing proof of association between WC and visceral fat; iv) race, age and sex can confound the association of WC with T2D; and v) WC, like BMI, is a highly heritable trait that may capture genetic similarity rather than risk of T2D.([@R18], [@R20], [@R21]) It is noteworthy in this regard that direct or associative evidence in favor of WC that is primarily based on the biological underpinnings of T2D/IR pathogenesis is currently weak.

There is now a growing interest in the characterization of the vast repertoire of plasma lipids and their potential contributions to several complex diseases.([@R22], [@R23], [@R24], [@R25]) Of special interest, plasma lipid species as measured by lipidomic profiling are being increasingly associated with the risk of T2D/IR and have been shown to be better predictors than the lipoprotein fractions that are commonly used in clinical practice.([@R26], [@R27], [@R28]) In this context, we reasoned that associations of key plasma lipid species with WC could lend further biologically meaningful support to the candidature of WC as a crucial link between obesity and T2D/IR. In this regard, whether WC is associated with the enormous variety of plasma lipids is currently unknown. Here we investigated the potential association of a large array of plasma lipid species with WC using rich data from the ongoing San Antonio Family Heart Study ([@R29]) in large and extended Mexican American families -- a high risk population for both obesity and T2D/IR.

METHODS AND PROCEDURES {#S6}
======================

Study participants {#S7}
------------------

The San Antonio Family Heart Study (SAFHS) is an ongoing effort focusing on 1,431 individuals from 42 large, extended Mexican American families in San Antonio. Details of this collaborative study have been described elsewhere.([@R21], [@R29]) Briefly, the SAFHS aims to quantify the relative contributions of genetic and environmental factors to the risk of developing cardiovascular diseases and metabolic syndrome. Extensive phenotypic assessment for a number of traits related to metabolic syndrome has been performed in these individuals. This project involving the Texas Biomedical Research Institute and the University of Texas Health Science Center at San Antonio was initiated in 1991. Informed consent was obtained from all participants before collection of samples. The Institutional Review Board of the University of Texas Health Sciences Center at San Antonio approved the study. Using this data, we aimed to determine the association of the plasma lipid species with concurrently and cross-sectionally measured WC.

Lipidomic studies {#S8}
-----------------

Samples were analysed in the Metabolomics Laboratory at the Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Analytical methods have been detailed elsewhere.([@R30]) Briefly, a 10µL aliquot of plasma was combined with 200µL CHCl~3~/MeOH (2:1) and 15µL of internal standard mix and then briefly vortexed. Samples were mixed (rotary mixer, 10 min), sonicated (water bath, 30 min) then allowed to stand (20 min) at room temperature. Samples were centrifuged (16,000×g, 10 min) and the supernatant was dried under a stream of nitrogen at 40°C. The extracted lipids were resuspended in 50µL H~2~O saturated BuOH with sonication (10 min), followed by 50µL of 10 mM NH~4~COOH in MeOH. Extracts were centrifuged (3,350×g, 5 min) and the supernatant transferred into 0.2mL glass vials with teflon insert caps. Mass spectrometric analysis was performed using 5µL and 1µL \[for diacylglycerol and triacylgrlycerol (DG and TG, respectively) species\] injections of the lipid extracts.

Identification and quantitation of lipid species was performed by liquid chromatography electrospray ionisation-tandem mass spectrometry using an Applied Biosystems 4000 QTRAP. Liquid chromatography was performed on a Zorbax C18, 1.8 µm, 50 × 2.1 mm column at 300 µL/min using the following gradient conditions; 0% B to 100% B over 8.0 min, 2.5 min at 100% B, a return to 0% B over 0.5 min then 3.0 min at 0% B prior to the next injection. DGs and TGs were separated using the same solvent system with an isocratic flow (100µL/min) of 85% B. Solvent A and B consisted of tetrahydrofuran:methanol:water in the ratios (30:20:50) and (75:20:5) respectively, both containing 10mM NH~4~COOH. Precursor ion scans and neutral loss scans were used to identify the lipid species present in human plasma. Quantification of individual lipid species was then performed using scheduled multiple-reaction monitoring (MRM) in positive ion mode.([@R31], [@R32]) Lipid concentrations were calculated by relating the peak area of each species to the peak area of the corresponding internal standard. CE species were corrected for response factors determined for each species. Total measured lipids of each class were calculated by summing the individual lipid species.

Statistical analysis {#S9}
--------------------

Our analyses were designed with the aim to minimize the number of statistical tests. For this, we conducted the statistical analyses at two levels: lipid classes and lipid species. To assess the association of each lipid class with WC, we used a three-step procedure ([Fig 1](#F1){ref-type="fig"}). First, we ran a polygenic regression model in which we included all the lipid species within a given class as covariates (base model, denoted as M~1~ in [Fig 1](#F1){ref-type="fig"}). These regression models included age, age^2^, sex, age × sex interaction and age^2^ × sex interaction, BMI, homeostasis model of assessment -- insulin resistance (HOMA-IR), use of lipid lowering drugs, total plasma cholesterol, plasma triglycerides and plasma high-density (HDL) lipoproteins as additional covariates. Second, we ran a model by constraining the regression coefficients of all the lipid species within the class to be equal (alternative model, denoted as M~2~ in [Fig 1](#F1){ref-type="fig"}) and third, we ran another model by constraining these regression coefficients to be zero (null model, denoted as M~3~ in [Fig 1](#F1){ref-type="fig"}). The alternative model provided the regression coefficient for the mean of all lipid species within a class while comparison of the log-likelihoods of the alternative model and the null model gave a test for the significance of this mean regression coefficient. Further, comparison of the log-likelihoods from the base model and the alternative model provided a test for heterogeneity of associations within the given lipid class.

We next examined the association of lipid species with WC. In these analyses, we selected the lipid species that represented one of the following two types of lipid classes: i) a lipid class showing statistically significant association of the mean of all lipid species within that class and statistically non-significant within-class heterogeneity; or ii) a lipid class showing statistically significant within-class heterogeneity. For this, we ran polygenic models with the given lipid species as the covariate and tested the statistical significance by constraining this regression coefficient to zero and then estimating χ^2^ as −2(LL~unconstrained\ model~ − LL~constrained\ model~), where LL represents the log-likelihood.

Next, we conducted bivariate trait analyses in which we used each lipid species in a separate bivariate polygenic model along with WC as the two traits. Using this series of models and variance components methods we estimated the genetic correlation (ρ~g~) and the environmental correlation (ρ~e~) coefficients as described elsewhere.([@R33]) The statistical significance of these correlation coefficients was tested by constraining the respective parameters to zero and estimating the χ^2^ statistics as mentioned above. All genetic analyses were conducted using the Sequential Oligogenic Linkage Analysis Routines (SOLAR) software.([@R33]) Statistical significance was assessed at a global type I error rate of 0.05 and, where appropriate, the false discovery rate (FDR) approach using the method of Benjamini and Hochberg was used to correct for multiple comparisons.

RESULTS {#S10}
=======

Study subjects {#S11}
--------------

Cross-sectional data on lipidomic profiles and WC was available on 1208 subjects representing 42 extended families. The mean age of the study sample was 37.0 (SD 14.39) years and there were 292 (36.1%) males. Prevalence of IR was 74.6% based on a HOMA-IR cut-off of 2.6 (the commonly used clinical cut-point for IR) and 56.1% using a cut-off of 3.8 (as specifically recommended([@R34]) for Mexican-American populations). The prevalence of T2D and obesity in this sample was 14.8% and 38.3%, respectively.

Association of plasma lipid classes with WC {#S12}
-------------------------------------------

To optimize the number of statistical tests being performed, we first conducted our analyses at the level of lipid classes. We studied the association of 23 lipid classes listed in [Table 1](#T1){ref-type="table"} with WC. In multivariable polygenic regression models including the aforementioned covariates, we found ([Fig 2](#F2){ref-type="fig"}) that the standardized regression coefficient (class-specific regression coefficient divided by its standard error) for the class of dihydroceramides was the only statistically significant (FDR-corrected p = 0.0003) class-level regression coefficient. Interestingly, the FDR-corrected heterogeneity around this mean class effect for dihydroceramides was not statistically significant (p = 0.5489, [Table 1](#T1){ref-type="table"}) indicating that the six species constituting this class were likely associated with WC in a homogeneous fashion. No other class of plasma lipids was significantly associated with WC. It is noteworthy in this regard that ceramides have been previously implicated in the pathogenesis of T2D and IR, but we found no significant association of this class with WC (mean class effect = 0.0024, SE = 0.0039, p = 0.5398).

Association of lipid species with WC {#S13}
------------------------------------

We next examined the association of lipid species with WC. Based on the results shown in [Table 1](#T1){ref-type="table"}, we selected 60 lipid species belonging to the following five classes: dihydroceramides (6 species), dihexocylceramides (6 species), sphingomyelins (19 species), plasmalogen phosphatidylcholines (8 species) and lysophosphatidylcholines (21 species). Consistent with the results at the level of lipid class, we found ([Table 2](#T2){ref-type="table"}) that four (dhCer 24:1, dhCer 18:0, dhCer 20:0 and dhCer 22:0) of the six dihydroceramide species were statistically significantly associated with WC. In addition, two sphingomyelin species (SM 31:1 and SM 41:1) were also significantly associated with WC. Interestingly however, most of the sphingomyelin species were inversely associated with WC.

Genetic correlations of lipid species with WC {#S14}
---------------------------------------------

To glean further biologically meaningful support for the clinical utility of WC, we conducted bivariate trait analyses in SOLAR and estimated the genetic and environmental correlations of each significantly associated lipid species with WC. We observed ([Table 3](#T3){ref-type="table"}) that the dihydroceramide 22:0 and dihydroceramide 24:1 species were significantly genetically correlated with WC. In contrast, the dihydroceramide 18:0 and dihydroceramide 20:0 species were significantly environmentally but not genetically correlated with WC. Of note, both the sphingomyelin species were significantly environmentally but not genetically correlated with WC.

DISCUSSION {#S15}
==========

Our results demonstrate that dihydroceramides as a lipid class are consistently associated with WC in Mexican Americans. Of the six dihydroceramide species investigated in this study, four species showed a strong association with WC and were significantly genetically as well as environmentally correlated with WC. Notably, we have recently found dihydroceramides to be crucial determinants of future risk of T2D also.([@R35]) In that study (data not shown), we identified 210 lipid species that correlated with diabetes status (FDR ≤ 0.05); of which 128 also predicted progression to diabetes in non-diabetics followed for \~10 years. The single best predictor of progression to diabetes was dhCer 18:0 which was significantly heritable (h^2^ = 0.247; p = 1.6×10^−9^) and was markedly increased in diabetics (p = 2.5×10^−7^) compared to non-diabetics. Those non-diabetics who progressed to diabetes during follow-up also showed higher dhCer 18:0 levels at baseline than non-progressors (p = 2.2×10^−8^). This predictive relationship was maintained (p = 1.2×10^−4^) even when baseline fasting glucose and insulin levels were taken into account, indicating that this lipid component appears to be an independent predictor of diabetes risk. Considering these observations in totality, our results are novel, important and informative in support of the use of WC as a screening tool for T2D/IR risk in Mexican Americans.

The exact mechanistic basis of the observed association between dihydroceramides and waist circumference is currently unknown. It is also unclear whether the plasma dihydroceramide concentrations are better representative of the visceral fat or the subcutaneous fat -- a point of debate in the value of WC as a predictor of T2D.([@R18]) It has been long recognized that dihydroceramides are the biosynthetic precursors of ceramides -- a lipid class that partakes in the release of cytochrome C from mitochondria.([@R36]) Moreover, there is evidence ([@R37]) to suggest that de novo accumulation of ceramides can be detrimental to pancreatic beta cells and can thus initiate the pathogenesis of T2D. Ceramides are also known to participate in the DES1 pathway and thereby modify the risk of T2D/IR. Conceivably, the plasma concentrations of dihydroceramides may be indicative of raised intracellular levels of ceramides especially since the DES2 pathway is involved in the conversion of dihydroceramides to ceramides, ([@R38]) but data in this regard are currently lacking. It is also interesting to note from our results that plasma levels of ceramides and dihydroceramides have differential strengths of association with WC and it is unclear which of these classes might more faithfully represent pathways that implicate intracellular ceramide levels. In the absence of direct evidence however, the potential involvement of the DES1/DES2 should be considered only conjectural at this point in time. Future studies therefore need to identify the genetic and biological bases for the strong association of dihydroceramides with waist circumference observed in this study.

An interesting observation made in this study relates to the inverse association of two sphingomyelin species (SM 31:1 and SM 41:1) with waist circumference. This is somewhat surprising considering the general understanding that sphingomyelins are associated with increased risk of obesity, atherosclerosis and metabolic syndrome. However, Cantrell Stanford et al ([@R39]) have recently shown a potentially beneficial role of sphingolipids in the plasma membrane of pancreatic beta cells such that higher levels of these sphingolipids can facilitate glucose-stimulated insulin secretion and thereby improve glycemic control. Whether plasma levels of sphingomyelins faithfully capture the sphingolipid levels in beta cells is currently not known and needs to be investigated in future studies.

An important methodological implication of our results relates to the trade-off between simplicity and accuracy in the reporting of lipidomic studies. It is intuitively appealing to summarize and present the results at the level of lipid classes. However, results shown in [Table 1](#T1){ref-type="table"} clearly demonstrate that such a class-based synopsis may be an oversimplification of the underlying spectrum of species-specific associations. The within-class heterogeneity of associations should not be neglected. These results also concur with earlier observations that some (but not all) TGs are more significantly associated with HOMA-IR. For example, Kotrenon et al ([@R27]) found that only TG 16:0 16:0 18:1 was a significant predictor of HOMA-IR. Together, these results indicate that the enhanced resolution offered by lipidomic studies can be used advantageously to characterize lipidomic associations with various disease states.

In addition to the fact that we did not have information on visceral and subcutaneous lipid profiles, some other limitations of the study also need to be considered. First, ethnicity, age and sex are known to confound the association of WC with the risk of T2D and insulin resistance.([@R18]) Whether these confounders are also operative in the context of the association of WC with the plasma lipid profile remains unknown. In our analytical protocol we included age, sex and interactions thereof as covariates in all the polygenic models. Therefore, our results are unlikely to be affected by the age and sex composition of this cohort. However, this study was conducted only in Mexican-Americans and therefore cannot be generalized to other ethnic populations. Second, WC is a heritable trait ([@R20], [@R21], [@R40]) and therefore beckons a need for appropriate statistical models in the family settings. Our use of polygenic models isolates the heritable and modifiable components of WC. Our results are thus unlikely to be affected by the heritability of WC.

On the other hand, our study has several strengths. To our knowledge, this is the first study providing associative evidence for the relationship between WC and dihydroceramides. Second, large-scale plasma lipid studies with epidemiologic overtones are still in the stage of infancy. To that end we believe that our observations are both novel and important. Lastly, our results proffer additional and indirect biological credence to the established role of WC in the pathogenesis of T2D and IR in high prevalence scenarios.
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![Statistical method used to study the association of a class of lipids with a phenotypic trait\
A lipid class is a collection of s lipid species (rectangle on the left). For a given lipid class, three models (M~1~, M~2~ and M~3~ described in a tabular format on the right) were run and log-likelihoods from these three models were used as shown at the bottom to estimate the mean effect, its statistical significance and heterogeneity of within-class associations. For details, refer to text.](nihms512959f1){#F1}

![Associations of the lipid classes with WC\
The strength of the association of each lipid class is shown as z-score (the class-specific regression coefficient divided by its standard error) estimated from polygenic regression models and the statistical significance of this association is indicated by the asterisk on the right.](nihms512959f2){#F2}

###### 

Within-lipid class heterogeneity of association with WC

  -------------------------------------------------------------------------------------------
  Lipid class                              Class    Lipid\    Nominal\        FDR adjusted\
                                                    species   within-class\   within-class\
                                                              Heterogeneity   Heterogeneity
  ---------------------------------------- -------- --------- --------------- ---------------
  Dihydroceramide                          dhCer    6         3.92×10^−2^     0.5489

  Ceramide                                 Cer      6         2.12×10^−2^     0.3392

  Monohexosylceramide                      MHC      6         9.49×10^−2^     0.6090

  Dihexosylceramide                        DHC      6         1.27×10^−4^     0.0027

  Trihexosylceramide                       THC      6         1.24×10^−1^     0.6090

  GM3 ganglioside                          GM3      6         7.20×10^−3^     0.1296

  Sphingomyelin                            SM       19        9.22×10^−5^     0.0020

  Phosphatidylcholine                      PC       45        4.43×10^−2^     0.5489

  Ether-linked phosphatidylcholines        PC(O)    18        4.68×10^−2^     0.5489

  Plasmalogen phosphatidylcholines         PC(P)    8         1.85×10^−3^     0.0370

  Lysophosphatidylcholine                  LPC      21        2.31×10^−3^     0.0439

  Ether-linked lysophosphatidylcholines    LPC(O)   6         9.68×10^−1^     0.9680

  Phosphatidylethanolamine                 PE       18        4.99×10^−2^     0.5489

  Ether-linked phosphatidylethanolamines   PE(O)    12        1.38×10^−1^     0.6090

  Plasmalogen phosphatidylethanolamines    PE(P)    9         1.82×10^−1^     0.6090

  Lysophosphatidylethanolamine             LPE      6         3.95×10^−1^     0.7900

  Phosphatidylinositol                     PI       17        1.20×10^−1^     0.6090

  Phosphatidylserine                       PS       7         1.75×10^−1^     0.6090

  Phosphatidylglycerol                     PG       4         2.03×10^−1^     0.6090

  Cholesterol ester                        CE       26        1.53×10^−1^     0.6090

  Cholesterol                              COH      1         \-\--           \-\--

  Diacylglycerol                           DG       22        7.64×10^−3^     0.1299

  Triaclyglycerol                          TG       43        4.86×10^−2^     0.5489
  -------------------------------------------------------------------------------------------

###### 

Multivariable association[\*](#TFN1){ref-type="table-fn"} of plasma dihydroceramide species with WC

  Lipid species   β         Nominal p      FDR-p
  --------------- --------- -------------- -----------------
  dhCer 16:0      0.0354    1.19×10^−2^    4.89×10^−1^
  dhCer 18:0      0.0706    1.82×10^−5^    **1.06×10^−3^**
  dhCer 20:0      0.0687    1.42×10^−5^    **8.38×10^−4^**
  dhCer 22:0      0.0615    4.84×10^−4^    **2.66×10^−2^**
  dhCer 24:0      0.0456    4.98×10^−3^    2.49×10^−1^
  dhCer 24:1      0.0835    3.51×10^−7^    **2.11×10^−5^**
  Cer 16:0        0.0244    1.06×10^−01^   4.89×10^−1^
  Cer 18:0        0.0310    4.15×10^−02^   4.89×10^−1^
  Cer 20:0        0.0093    3.07×10^−01^   4.89×10^−1^
  Cer 22:0        −0.0183   1.77×10^−01^   4.89×10^−1^
  Cer 24:0        −0.0330   4.95×10^−02^   4.89×10^−1^
  Cer 24:1        0.0351    3.23×10^−02^   4.89×10^−1^
  DHC 16:0        0.0007    4.83×10^−1^    4.89×10^−1^
  DHC 18:0        0.0052    3.67×10^−1^    4.89×10^−1^
  DHC 20:0        0.0413    1.70×10^−3^    9.18×10^−2^
  DHC 22:0        0.0096    2.57×10^−1^    4.89×10^−1^
  DHC 24:1        0.0298    2.50×10^−2^    4.89×10^−1^
  DHC 24:0        0.0091    2.78×10^−1^    4.89×10^−1^
  SM 31:1         −0.0652   1.26×10^−4^    **7.18×10^−3^**
  SM 32:1         −0.0196   1.58×10^−1^    4.89×10^−1^
  SM 32:2         −0.0180   2.00×10^−1^    4.89×10^−1^
  SM 33:1         −0.0496   3.55×10^−3^    1.81×10^−1^
  SM 34:1         −0.0034   4.29×10^−1^    4.89×10^−1^
  SM 34:2         0.0141    2.65×10^−1^    4.89×10^−1^
  SM 34:3         −0.0217   1.18×10^−1^    4.89×10^−1^
  SM 35:1         −0.0368   1.56×10^−2^    4.89×10^−1^
  SM 35:2         −0.0433   5.83×10^−3^    2.86×10^−1^
  SM 36:1         0.0191    1.45×10^−1^    4.89×10^−1^
  SM 36:2         −0.0085   3.24×10^−1^    4.89×10^−1^
  SM 36:3         −0.0320   3.15×10^−2^    4.89×10^−1^
  SM 37:2         −0.0332   2.43×10^−2^    4.89×10^−1^
  SM 38:1         −0.0179   1.20×10^−1^    4.89×10^−1^
  SM 38:2         −0.0207   9.77×10^−2^    4.89×10^−1^
  SM 39:1         −0.0226   6.47×10^−2^    4.89×10^−1^
  SM 41:1         −0.0673   3.58×10^−4^    **2.00×10^−2^**
  SM 41:2         −0.0396   7.96×10^−3^    3.82×10^−1^
  SM 42:1         −0.0362   3.35×10^−2^    4.89×10^−1^
  LPC 14:0        0.0069    3.28×10^−1^    4.89×10^−1^
  LPC 15:0        −0.0423   2.45×10^−3^    1.30×10^−1^
  LPC 16:0        −0.0073   3.10×10^−1^    4.89×10^−1^
  LPC 16:1        0.0214    7.56×10^−2^    4.89×10^−1^
  LPC 17:0        −0.0270   2.81×10^−2^    4.89×10^−1^
  LPC 17:1        −0.0134   1.86×10^−1^    4.89×10^−1^
  LPC 18:0        0.0134    1.95×10^−1^    4.89×10^−1^
  LPC 18:1        −0.0137   1.72×10^−1^    4.89×10^−1^
  LPC 18:2        −0.0237   6.78×10^−2^    4.89×10^−1^
  LPC 18:3        0.0214    7.85×10^−2^    4.89×10^−1^
  LPC 20:0        −0.0084   3.06×10^−1^    4.89×10^−1^
  LPC 20:1        −0.0042   3.98×10^−1^    4.89×10^−1^
  LPC 20:2        −0.0035   4.04×10^−1^    4.89×10^−1^
  LPC 20:3        −0.0044   3.88×10^−1^    4.89×10^−1^
  LPC 20:4        0.0079    3.05×10^−1^    4.89×10^−1^
  LPC 20:5        0.0198    9.77×10^−2^    4.89×10^−1^
  LPC 22:0        −0.0083   2.98×10^−1^    4.89×10^−1^
  LPC 22:1        0.0106    2.48×10^−1^    4.89×10^−1^
  LPC 22:6        −0.0048   3.68×10^−1^    4.89×10^−1^
  LPC 24:0        −0.0101   2.68×10^−1^    4.89×10^−1^
  LPC 26:0        −0.0004   4.89×10^−1^    4.89×10^−1^
  PC(P-32:0)      0.0237    6.05×10^−2^    4.89×10^−1^
  PC(P-32:1)      0.0220    7.65×10^−2^    4.89×10^−1^
  PC(P-34:1)      −0.0115   2.49×10^−1^    4.89×10^−1^
  PC(P-34:2)      −0.0426   2.91×10^−3^    1.51×10^−1^
  PC(P-36:2)      −0.0242   5.56×10^−2^    4.89×10^−1^
  PC(P-36:5)      −0.0026   4.31×10^−1^    4.89×10^−1^
  PC(P-38:5)      −0.0052   3.66×10^−1^    4.89×10^−1^
  PC(P-40:5)      0.0105    2.32×10^−1^    4.89×10^−1^

All models are adjusted for age, age^2^, sex, age × sex, age^2^ × sex, use of lipid lowering medications, body mass index, HOMA-IR, total serum cholesterol, serum triglycerides and serum high density lipoproteins.

FDR-p, Corrected significance value using Benjamini and Hochberg's method of controlling false discovery rate

###### 

Bivariate trait analyses[\*](#TFN3){ref-type="table-fn"} of lipid species with WC

  Lipid species   ρ~g~      P~g~     ρ~e~      P~e~
  --------------- --------- -------- --------- ----------
  dhCer 18:0      0.1972    0.2228   0.1053    0.0001
  dhCer 20:0      0.2779    0.0889   0.0801    0.0001
  dhCer 22:0      0.4221    0.0038   −0.0297   0.0056
  dhCer 24:1      0.4557    0.0017   0.0338    \<0.0001
  SM 31:1         −0.2193   0.0829   −0.0640   0.0008
  SM 41:1         −0.2660   0.0727   −0.0423   0.0022

All models are adjusted for age, age^2^, sex, age × sex, age^2^ × sex, use of lipid lowering medications, body mass index, HOMA-IR, total serum cholesterol, serum triglycerides and serum high density lipoproteins.

ρ~g~, genetic correlation coefficient; P~g~, significance value for genetic correlation coefficient; ρ~e~, environmental correlation coefficient; P~e~, significance value for environmental correlation coefficient

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT? {#S17}
=========================================

-   Central obesity is a pathophysiological predeterminant of insulin resistance and type 2 diabetes

-   Waist circumference, the clinical marker of central obesity, is a useful screening tool for the prediction of type 2 diabetes risk

WHAT THIS STUDY ADDS? {#S18}
=====================

-   This study investigates the independent association of plasma lipidomic repertoire with waist circumference

-   Dihydroceramides are independently associated as well as genetically correlated with waist circumference in Mexican Americans
